Hope for an ME/CFS Autoimmune Subset: A German Researcher Steps Forward
Carmen Scheibenbogen is unusual. Not only has she become one of the most prolific ME/CFS researchers of the past few years but she’s doing her research from a country – Germany – which hardly acknowledges the disease’s existence. Plus,...
Small Nerves – Big, Big Problem? Drug Trial Points Finger at Autoimmunity in Fibromyalgia and ME/CFS
Difference-Maker Unlike FMS, SFPN has identifiable pathology, physiology, and causes, and thus is definitionally a disease. Oaklander et. Al. Dr. Anne Oaklander MD, PhD, is making a difference – maybe a very big difference in the lives of many. Making a...
Norwegian Rituximab Chronic Fatigue Syndrome (ME/CFS) Trial Fails
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
Early Results Suggest Two Radically Different Immune Subsets Present in Chronic Fatigue Syndrome (ME/CFS)
Subsets, Subsets, Subsets Everyone with ME/CFS who’s been around a bit must ask themselves at some point, “Do I have what she or he has?” Some people do great on treatments that others fail on. Some people get really, really sick while others...
A Biomarker for Chronic Fatigue Syndrome (ME/CFS)? Immunosignature Provides Another Possibility
A Different Look at the Immune System The ultimate goal of this work is the development of a non-subjective clinical tool for diagnosing patients with ME. Lombardi et. al. Last month Health Rising looked at a potential ion channel biomarker coming out of the NCNED in...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
